TRANSFUSION COMPLICATIONS: Improvement of an ultrasensitive human immunodeficiency virus Type 1 real‐time reverse transcriptase–polymerase chain reaction targeting the long terminal repeat region
Authors:
- 1 March 2010
- journal article
- Published by Wiley in Transfusion
- Vol. 50 (3) , 685-692
Abstract
BACKGROUND: Human immunodeficiency virus Type 1 (HIV‐1) assays applying nucleic acid testing (NAT) rely on HIV‐1 sequence‐specific primers and probes. Their hybridization can be limited or abolished by genetic polymorphisms occurring in the target sequence.STUDY DESIGN AND METHODS: Blood donations are routinely tested for HIV‐1/2 antibodies and for HIV‐1 RNA in our blood transfusion unit. Recently, HIV‐1 RNA was undetectable with an established in‐house real‐time long terminal repeat (LTR) reverse transcriptase–polymerase chain reaction (RT‐PCR) in two cases, whereas serologic assays were positive. The reason for this discrepancy was elucidated by sequencing of the NAT target region in the respective single donations. An improved primer was designed and tested on HIV‐1 reference panels and blood donations to ensure reliable detection of HIV‐1 RNA.RESULTS: Direct sequencing of the target region, isolated from samples of two unrelated HIV‐positive blood donors, revealed one and four mismatches in the hybridization domain of the forward primer, respectively. Both viruses belong to HIV‐1 Subtype B. LTR RT‐PCR with an additional forward primer was suitable for all strains of HIV‐1 tested with high sensitivity.CONCLUSIONS: Surveillance of HIV‐1 genetic diversity is essentially required to continually evaluate its impact on performance of diagnostic and patient monitoring assays.Keywords
This publication has 28 references indexed in Scilit:
- HIV/AIDS surveillance in Europe: update 2007Eurosurveillance, 2008
- Noninfectious transfusion of platelets donated before detection of human immunodeficiency virus RNA in plasmaTransfusion, 2008
- Antiretroviral Treatment of Adult HIV InfectionJAMA, 2008
- The spread, treatment, and prevention of HIV-1: evolution of a global pandemicJournal of Clinical Investigation, 2008
- Evaluation of the Roche Cobas TaqMan and Abbott RealTime Extraction-Quantification Systems for HIV-1 SubtypesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Can Routine Clinical Markers Be Used Longitudinally to Monitor Antiretroviral Therapy Success in Resource‐Limited Settings?Clinical Infectious Diseases, 2007
- Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical ManagementThe Journal of Infectious Diseases, 2005
- Impact of Human Immunodeficiency Virus Type 1 (HIV-1) Genetic Diversity on Performance of Four Commercial Viral Load Assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QTJournal of Clinical Microbiology, 2005
- Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification TestingNew England Journal of Medicine, 2004
- Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseasesTransfusion, 2000